Global Live Cell Imaging Market: Global Size, Trends, Competitive, Historical & Forecast Analysis, 2021-2028: Factors such as increasing demand of live cell imaging systems in drug discovery, its growing adaption in cancer research, rising government investments or findings for development and advancement in this field are some major factors driving the growth of the market.
Global Live Cell Imaging Market is valued at USD 1724.5 Million in 2021 and is expected to reach USD 3072.4 Million by 2028 with a CAGR of 8.6% over the forecast period.
Live-cell imaging is a specific tool for cellular research with wide variety of applications. By streaming digital microscopic images, an observer can observe dynamic morphology of cell, can track cell movement on the surface and can measure fluorescently labeled proteins or molecules. These single cell imaging systems are designed to operate the inside cell culture incubator and enable to maintain the cells under optimum conditions. It is a vital tool for getting maximum information from precious cell samples.
Also, it allows observations of cell interaction, the behavior of the cell. By using livecell imaging it is possible to study how molecules translocate, interact and respond to environmental cues. Also some imaging systems are able to monitor the molecules within live animals. Live-cell imaging offers spatial & temporal information of dynamic events in single cells, cellular networks (in situ) or even whole organisms (in vivo). There are some microscopic methods applied for live cell imaging such as time lapse imaging, advanced fluorescence techniques such as ion imaging, FRET (Froster Resonance Energy Transfer), TIRF (Total Internal Reflection) microscopy, MPE (Multiphoton Excitation).
Covid-19 pandemic have a shown mixed impact on global live cell imaging market. Due to this pandemic lockdown, social distancing is announced by governments of many of countries and also many labs are being forced to scale back research as lab personnel are often required to work in shifts. However, a live-cell imaging microscope offers the advantage of moving forward as it can allow for researchers at home (or anywhere with an internet connection) to monitor cell growth dynamics. This opens up the lab for other researchers to do more work off-site and provides more hours in the day for other scheduled tasks. Altogether, live-cell imaging systems will make a lab more efficient in a time where efficiency is more essential than ever.
Global live cell imaging market is segmented on the basis of type, technologies, end users and regional & country level. on the basis of type, the market is classified into instruments, microscopes, standalone systems, cell analyzers, accessories, consumables, reagents. On the basis of technology, the market is classified into time-lapse microscopy, fluorescence resonance energy transfer (FRET), fluorescence recovery after photo bleaching (FRAP), high-content screening (HCS). On the basis of end-users, global live cell imaging market is classified into pharmaceutical & biotechnology companies, academic & research institute.
The regions covered in this global live cell imaging market report are North America, Europe, Asia-Pacific, and the Rest of the World. On the basis of country level, the market of live cell imaging is sub divided into U.S., Mexico, Canada, UK, France, Germany, Italy, China, Japan, India, South East Asia, GCC, Africa, etc.
Major key players of the global live cell market are
Increasing demand of live cell imaging system in drug discovery and government investments or findings for development and advancement in live cell imaging system are some of the major factors drive the growth of the market. As knowing cellular structure and dynamic processes can be critical in the study of cell biology, live cell imaging system solves this problem. As live cell usually provides more relevant information, it provides data about cell interaction, behavior of single cells and dynamics of cell organelles. In addition, increasing number of product offerings also supplementing the market growth.
For example; in July 2020, InnoME, Gmbh and Etaluma, Inc. announced a partnership and launched entry level incubator cell imaging to the Americas. In addition, growing prevalence of cancer disease is also augmenting the market demand for live cell imaging. As Cancer has a major impact on society as it cancer most harmful disease in the world.
For example; according to American Cancer Society projections, there are 1,806,590 new cases of cancer are expected to be diagnosed in 2020, in which 1,91,930 cases are of prostate cancer, 2,79,100 cases of breast cancer 2,28,820 cases of lung cancer. As live cell imaging system used to observe how interactions between tumor and their microenvironment affect malignant progression.
However, high cost of live cell imaging instruments may hamper the growth of the market. In spite of that, increasing advancements to develop more innovative live cell imaging system can offer opportunities for future growth of the market.
Global live cell Imaging market is segmented into North America, Europe, Asia- Pacific Latin America and Middle East & Africa. North America is expected to dominate the global live cell imaging market within the forecast period due to increasing demand of live cell imaging for drug discovery and growing number of product launched in this region. In drug discovery, live cell imaging system helps in understanding the processes of cells which provides an enhanced picture of drug pharmacology.
For example: in May 2020, CytoSMART Technologies launched CytoSMART Lux2 Duo Kit, new live-cell imaging system. It is especially useful in stem cell research. This live cell imaging system allows inspecting the colonies formed by iPSC and also morphology.
Europe is projected to capture the second largest share of global live cell imaging market attributed to the increasing adoption of live cell imaging system in research and development activities in this region. Major aspect of live cell imaging is to establish criteria for determining the condition of the cell which is beneficial for research and development industries.
|Historical data||2015 - 2020|
|Forecast Period||2021 - 2028|
|Market Size in 2020:||USD 1724.5 Million|
|Base year considered||2020|
|Forecast Period CAGR %:||
|Market Size Expected in 2027:||USD 3072.4 Million|
|Tables, Charts & Figures:||175|
|Key Players/Companies||Danaher corporation, Carl Zeiss AG Nikon Corporation, Olympus Corporation, PerkinElmer, Inc., GE Healthcare, Bruker Corporation, Thermo Fisher Scientific Inc., Sartorius AG, Oxford Instruments, BioTek Instruments, Etaluma, Inc., CytoSMART Technologies, Phase Focus Limited , Tomocube, Inc., and others|
|Segments Covered||By Type, By Technology, By End-Users|
|Regional Analysis||North America, U.S., Mexico, Canada, Europe, UK, France, Germany, Italy, Asia Pacific, China, Japan, India, Southeast Asia, South America, Brazil, Argentina, Columbia, The Middle East and Africa, GCC, Africa, Rest of the Middle East and Africa|